Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Clinical Trial Phase IIB to Evaluate the Immunogenicity and Safety of Recombinant Novel Coronavirus Vaccine in Participants Aged 18 Years and Above That Previously Received One Dose of Sputnik V

NCT05293223 is registered in ClinicalTrials.gov with Fundación Huésped as lead sponsor.

NCT NCT05293223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Clinical Trial Phase IIB to Evaluate the Immunogenicity and Safety of Recombinant Novel Coronavirus Vaccine in Participants Aged 18 Years and Above That Previously Received One Dose of Sputnik V
Lead sponsor
Fundación Huésped
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2021
Completion date
December 15, 2023
Enrollment
88 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccine